All Generative AI articles

News

Insilico announces ISM6200 AI-designed drug candidate for ovarian cancer and cortisol disorders

2026-04-10T12:00:00Z

Insilico Medicine has nominated ISM6200, a preclinical drug candidate designed using generative AI to target NR3C1, a receptor involved in cortisol regulation.